These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 23470005)

  • 1. The smart targeting of nanoparticles.
    Friedman AD; Claypool SE; Liu R
    Curr Pharm Des; 2013; 19(35):6315-29. PubMed ID: 23470005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.
    Morachis JM; Mahmoud EA; Almutairi A
    Pharmacol Rev; 2012 Jul; 64(3):505-19. PubMed ID: 22544864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoparticles for oral drug and gene delivery.
    Bowman K; Leong KW
    Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
    Xu S; Olenyuk BZ; Okamoto CT; Hamm-Alvarez SF
    Adv Drug Deliv Rev; 2013 Jan; 65(1):121-38. PubMed ID: 23026636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted drugs and nanomedicine: present and future.
    Debbage P
    Curr Pharm Des; 2009; 15(2):153-72. PubMed ID: 19149610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification and local orientations of surface molecules in nanotherapeutics.
    Amin ML; Joo JY; Yi DK; An SS
    J Control Release; 2015 Jun; 207():131-42. PubMed ID: 25883030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine.
    Fang C; Zhang M
    J Control Release; 2010 Aug; 146(1):2-5. PubMed ID: 20493220
    [No Abstract]   [Full Text] [Related]  

  • 9. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery.
    Chavanpatil MD; Khdair A; Panyam J
    J Nanosci Nanotechnol; 2006; 6(9-10):2651-63. PubMed ID: 17048473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles.
    Pang L; Zhang C; Qin J; Han L; Li R; Hong C; He H; Wang J
    Drug Deliv; 2017 Nov; 24(1):83-91. PubMed ID: 28155538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into cellular uptake of nanoparticles.
    Kafshgari MH; Harding FJ; Voelcker NH
    Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for Intranasal Delivery to Improve Brain Uptake.
    Patel AA; Patel RJ; Patel SR
    Curr Drug Deliv; 2018; 15(4):461-469. PubMed ID: 29034836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in development of nanoparticle-based therapeutics.
    Desai N
    AAPS J; 2012 Jun; 14(2):282-95. PubMed ID: 22407288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of drug and nutritional components in nano-engineered form to increase delivery ratio and reduce current inefficient practice.
    Valtcheva-Sarker RV; O'Reilly JD; Sarker DK
    Recent Pat Drug Deliv Formul; 2007; 1(2):147-59. PubMed ID: 19075882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide ligand-mediated targeted drug delivery of nanomedicines.
    Jiang Z; Guan J; Qian J; Zhan C
    Biomater Sci; 2019 Jan; 7(2):461-471. PubMed ID: 30656305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.